Company News

Launch date Title
2021-06-01 TCA intermediate fumarate promotes mitobiogenesis
2021-05-03 RIP1 activation and pathogenesis of NASH
2021-04-01 arigo wins 2021 CiteAb award
2021-03-02 HMGB1, a biomarker and therapeutic target in COVID-19
2021-02-01 circNDUFB2, a circular RNA (circRNA), activates anti-tumor immunity
2021-01-04 Detecting exosomal HMGB1 for ICD research
2020-12-02 Anti-SerpinB9 therapy, a new strategy for cancer therapy
2020-11-02 Senescence Marker Antibody Panel is launched
2020-10-01 Simplify the ELISA analysis by GainData
2020-08-03 Astrocyte-to-neuron conversion for Parkinson's disease treatment
2020-07-01 Exploring Antiviral Immune Response
2020-06-01 Therapeutic strategies against PDAC
2020-05-08 Examining CTL/NK-mediated cytotoxicity by ELISA
2020-04-08 Ferroptosis/Oxytosis Antibody Panel is launched
2020-03-03 New HMGB1 neutralizing antibody is released
2020-02-07 ACE2, receptor of SARS-CoV-2
2020-02-03 Tumor immune microenvironment (TIME)
2020-01-06 The best solution for PD-1/PD-L1 research
2019-12-16 Detecting the DAMPs in cancer therapy by HMGB1 ELISA kit
2019-11-07 Detecting MMPs and their non-ECM substrates

arigo nuts about antibodies
© 2014-2023, arigo Biolaboratories Corp., All rights reserved
沪ICP备17000949号-1